Oncology Innovation Just Hit a Turning Point -- Here's What to Watch — Comtex11:08 AM ET 06/30/2025 VANCOUVER, BC, June 30, 2025 (PR Newswire Europe via COMTEX News Network) -- USA News GroupNews CommentaryIssued on behalf of Oncolytics Biotech Inc. |
Oncology Innovation Just Hit a Turning Point -- Here's What to Watch — Comtex11:03 AM ET 06/30/2025 Canada NewsWire |
Oncology Innovation Just Hit a Turning Point -- Here's What to Watch — Comtex11:03 AM ET 06/30/2025 VANCOUVER, BC, June 30, 2025 /PRNewswire via COMTEX News Network/ -- USA News GroupNews CommentaryIssued on behalf of Oncolytics Biotech Inc. |
Why Early-Onset Cancers Are Alarming Researchers--and What It Means for Investors — Comtex10:00 AM ET 06/30/2025 Jun 30, 2025 (Baystreet.ca via COMTEX News Network) -- Issued on behalf of Oncolytics Biotech Inc. |
Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy — Comtex07:00 AM ET 06/30/2025 SAN DIEGO and CALGARY, Alberta, June 30, 2025 /PRNewswire via COMTEX News Network/ -- Oncolytics Biotech®Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in... |
Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy — Comtex07:00 AM ET 06/30/2025 Canada NewsWire |
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough? — Comtex11:49 AM ET 06/26/2025 VANCOUVER, BC, June 26, 2025 (PR Newswire Europe via COMTEX News Network) -- USA News GroupNews CommentaryIssued on behalf of Oncolytics Biotech Inc. |
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough? — Comtex11:45 AM ET 06/26/2025 Canada NewsWire |
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough? — Comtex11:44 AM ET 06/26/2025 VANCOUVER, BC, June 26, 2025 /PRNewswire via COMTEX News Network/ -- USA News GroupNews CommentaryIssued on behalf of Oncolytics Biotech Inc. |
Investors Bet on Biotech as Public Cancer Research Hits a Wall — Comtex10:27 AM ET 06/26/2025 Jun 26, 2025 (Baystreet.ca via COMTEX News Network) -- Issued on behalf of Oncolytics Biotech Inc. |